NCT03751631 - Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 15, 2018

Primary Completion Date

January 11, 2019

Study Completion Date

January 11, 2019

Conditions

Mydriasis

Interventions

DRUG

Tropicamide 1%-Phenylephrine 2.5% ophthalmic solution (TR/PE)

Fixed combination tropicamide 1%-phenylephrine 2.5% ophthalmic solution administered with the Optejet microdose dispenser

DRUG

Tropicamide 1% ophthalmic solution (TR)

Tropicamide 1% ophthalmic solution administered with the Optejet microdose dispenser

DRUG

Phenylephrine 2.5% ophthalmic solution (PE)

Phenylephrine 2.5% ophthalmic solution administered with the Optejet microdose dispenser

Trial Locations (1)

WCCT, Cypress